Inversago Pharma
ID: 5330071Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade.
3
Funding Rounds
$110.7m
Money raised
Recent Funding Rounds
Overview
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Inversago Pharma has raised a total of $110.74m in funding over 3 rounds.
Key Insights:
- Inversago Pharma - Series C round, October 2022: $68.74m
- Inversago Series B round, September 2020: $35m
- Inversago Pharma Series A round, July 2018: $7m
Industries
Inversago Pharma is active in the following industries: